CD47 and ischemia: In animals, an intravenous TSP1 bolus impaired restoration of blood flow following short term (<1 h) ischemia and this was ameliorated by gene silencing of Nox1 or treatment with a CD47 antagonist antibody (Csanyi et al., 2012).